about
MicroRNAs and Endothelial (Dys) FunctionTreatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patientsApplications of propensity score methods in observational comparative effectiveness and safety research: where have we come and where should we go?Clinical outcomes of biodegradable polymer drug-eluting stents for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trialsUnderstanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatmentmTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and agingBio-Adaption between Magnesium Alloy Stent and the Blood Vessel: A ReviewFactors Associated with Lipid Goal Attainment among Patients with Deployed Drug Eluting StentThe impact of renal impairment on long-term safety and effectiveness of drug-eluting stentsNanotechnology in diagnosis and treatment of coronary artery disease.Application of quality by design (QbD) approach to ultrasonic atomization spray coating of drug-eluting stentsFeasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenariosComprehensive analysis of clinico-pathological data reveals heterogeneous relations between atherosclerosis and cancer.Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.Long-term outcomes of drug-eluting versus bare-metal stent for ST-elevation myocardial infarctionSpectral analysis related to bare-metal and drug-eluting coronary stent implantation.Preoperative management of antiplatelet drugs for a coronary artery stent: how can we hit a moving target?Healing the injured vessel wall using microRNA-facilitated gene delivery.A selective microRNA-based strategy inhibits restenosis while preserving endothelial function.Efficacy and safety of drug-eluting stents in the real world: 8-year follow-up.Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysismicroRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention.Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysisA cross-sectional study of stand-alone percutaneous coronary intervention in a Nigerian cardiac catheterization laboratoryDual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging.Enhancing physiologic simulations using supervised learning on coarse mesh solutionsDetermining the prevalence and predictors of sleep disordered breathing in patients with chronic heart failure: rationale and design of the SCHLA-HF registry.Curcumin- and natural extract-loaded nanofibres for potential treatment of lung and breast cancer: in vitro efficacy evaluation.An effective approach to reduce inflammation and stenosis in carotid artery: polypyrrole nanoparticle-based photothermal therapy.Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological studySry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells.Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes.Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR).Biomedical therapy using synthetic WKYMVm hexapeptideTransradial versus transfemoral rotablation for heavily calcified coronary lesions in contemporary drug-eluting stent eraEffect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosisBioengineered Corneas Grafted as Alternatives to Human Donor Corneas in Three High-Risk PatientsPercutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost-benefit analysisInhibition of early AAA formation by aortic intraluminal pentagalloyl glucose (PGG) infusion in a novel porcine AAA model.
P2860
Q26775547-D10FE7CC-533B-42A5-8CAA-135ED7FDD60EQ26780172-E2F5E766-A63A-46FE-B744-7072C83C8941Q26849372-65CFECA1-7215-4616-B676-EF0B2375820AQ26859403-8E4072C6-0C74-4AA9-90DA-51EC08D5601CQ28073031-CCEBDB2B-6ADE-4A4F-BC4B-D2FD6B180183Q28081442-3E269709-5732-4459-BEAB-EAB2E8B98A9BQ28390508-14CE0A24-FB8D-47D8-BA97-06D7B78EB94FQ28468714-27F6C94B-2E71-4974-B171-E0434ED2EADAQ28542739-6B52F5A2-6936-4BE3-97E2-3F66B8998705Q30362371-9375D296-0224-4898-ABA4-78773FDAEEADQ30394271-78E462B8-27DF-40DA-BB17-BF598137BC18Q30619558-541A6726-4B76-43D5-BF9E-E17CE64CA501Q30755617-D93FDFB8-9E08-4356-86E2-8FEB689C8C0EQ33791885-B45DC974-E518-4686-968B-88CFE1F3D8D4Q33835973-DCB5F2B6-0836-4E3C-B180-9F3FEA315058Q34114972-2A00EA77-0291-493C-9083-854AEDD2A012Q34116951-1414B267-675C-478F-8FF6-8F471E678CDFQ34117575-7B577AEB-7DE1-440C-9D84-98A95FEABC19Q34129012-A3FF02A6-5032-4D40-A07D-3F98E8659D9DQ34319885-C6045E60-1EF7-427E-BA22-87EB9754308BQ34452943-645DE430-F430-40B7-80DB-4F8C4599BB5FQ34504964-64E61104-C054-417D-8C1F-01E34321F53CQ34719102-8E91AC19-F9B8-4C4F-8EF3-37D5A42A1BE9Q35070809-8E220878-9685-474E-831B-DCF5E2141476Q35085450-5623C206-0B6D-48FC-BA1A-1025981FCF03Q35132471-482F3918-6945-4314-8476-CC53BF84CB68Q35134338-64C41CD2-FBA8-4FDC-A9C7-805AD8B9F5DAQ35143356-2CDB0142-2FAB-4197-84AF-A00074309F00Q35174770-5D6EA079-1999-44E1-A270-1762D577AEC0Q35592616-993DF99E-1540-47AC-A593-F46944CE0EC6Q35709080-B40B031A-AA16-4342-B292-D61B27ECB519Q35776368-FFB28671-6603-4EE0-91C4-F78729FA8589Q35830197-D0D15B8F-5706-4A55-B206-89906F1C6E9EQ35974060-CC67716D-4E48-4CF9-959E-1A767AA7E4ADQ35989727-2A650B2A-0130-47EB-ACB1-B574C6C63265Q36162173-B536BCF2-C2F4-47A7-8736-05317C882985Q36243208-66D577FA-78F0-4E07-901F-A45F7CEF83BCQ36366180-966A555C-7A88-4398-A140-B3748AE1FF07Q36370257-A76CEEB6-E069-40BA-B73E-841520BCF130Q36824186-7E8F4FF6-3E3E-45E2-8483-730EFB25439B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug-eluting coronary-artery stents.
@en
type
label
Drug-eluting coronary-artery stents.
@en
prefLabel
Drug-eluting coronary-artery stents.
@en
P356
P1476
Drug-eluting coronary-artery stents
@en
P2093
David R Holmes
P304
P356
10.1056/NEJMRA1210816
P407
P577
2013-01-01T00:00:00Z